Q7NB47 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidquca2imvnznuypmi3lgxq5jywkdrbhkwtxm63bcn2wosogwe7tu/metadata.json
IPFS of structure file: 
bafybeiacpzs2x2zlm252vphufdua6ydz3kws7zgvo4powuwdeohnnprtsq/AF-Q7NB47-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd139976F01d9eAE08b8AF23De4Bf3f70936ACdB8
First NFT owner address (bech32): 
genesis16yuewmcpm84wpzu27g77f0elwzfk4ndcl9525s
Current NFT ID #450177 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
450177
Accession (UniProt):
Q7NB47
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2))

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q7NB47 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q7NB47|SYL_MYCGA Leucine--tRNA ligase OS=Mycoplasma gallisepticum (strain R(low / passage 15 / clone 2)) OX=710127 GN=leuS PE=3 SV=1 MYNHNLIEKKWAKIWNDQKIYSFQIDKNKPKYYILDMFPYPSGKGLHVGHVKAYMATDVISRWKNALGFNVLHPIGWDAFGLPAEQYAIQTNNHPAKFTQENINNFRTQLKRLGFNYDYRLEVDTTNKNYFKWTQWIFKKLYEHDLAYQADIEVNWCEQLGTVLANEEVLTDENGNKISERGSYPVIKKKMRQWVLKITAFADQLIDDLENLNWPNSIKAMQVNWINKSVGASIKFEIDQLDNQTIEVFSSRADTLFGASFLALSFDHPLVKQKLITDKNNAIEQFIKDNSIDQRVRYQGINTNYFAIHPITKKKIPIYLADYILSDYGTGAVMGVPAHDERDYQFAKQYDLEIIPVIKADQYPYLLDGEHINSEFNNGLNNEQAIQKTIAYLREHNLGDQKINYKLRDWIFSRQRYWGEPFPVLFDEEDNIYLLKDSELPVELPQLSDFSPNKDGLPPLANADDQWLHPIIDQKKYRREINTMPQWAGSCWYYLAYLLKLTDLNQADGDQNYLALNSEKAKELFDHFMPVDLYVGGQEHAVLHLLYARFWYKFLHHIKIVSSTEPFSQLINQGMILGEDNTKMSKSKGNIINPDDLVLSHGADTIRTYVMFMGPLNASLAWNSNALNGTRKFLERVYNLFDRVEINDSINQNLNYDYHNFLKKINKHLENFEFNLVVSEMMIFINACYKQTQVNKEMITNFLIVLSFFAPYLAEELNSKLNNPTLLYKMRLAQWDEAYLVKNTTTISCSINGKFKLVHEFDLDSDEQEVANYFLNQDLIKRNLENKKLVKTIFVKNKVINFIIK